Cannabis, inhibitory neurons, and the progressive course of schizophrenia.
Freedman
Robert
R
D002186:Cannabinoids / Q000009:adverse effects / Q000494:pharmacology; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology; D015897:Comorbidity; D006801:Humans; D007150:Immunohistochemistry; D002189:Marijuana Abuse / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology*; D009433:Neural Inhibition / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism; D043884:Receptor, Cannabinoid, CB1 / Q000187:drug effects / Q000502:physiology; D012559:Schizophrenia / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology; D009435:Synaptic Transmission / Q000187:drug effects
D002186:Cannabinoids; D043884:Receptor, Cannabinoid, CB1